|
May 14
|
Alcon (ALC) Q1 Earnings Surpass Estimates, Margins Expand
|
|
May 14
|
Health Care Roundup: Market Talk
|
|
May 13
|
Compared to Estimates, Alcon (ALC) Q1 Earnings: A Look at Key Metrics
|
|
May 13
|
2 Intriguing Medical Stocks to Buy for Steady Growth as Earnings Approach
|
|
May 13
|
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
|
|
May 10
|
Why Alcon (ALC) Might Surprise This Earnings Season
|
|
May 8
|
Alcon Announces Results of 2024 Annual General Meeting
|
|
May 5
|
Questor: this medical stock is expensive – but worth paying for
|
|
Apr 7
|
Alcon Publishes Agenda for 2024 Annual General Meeting
|
|
Apr 3
|
Here's Why Investors Should Buy Alcon (ALC) Stock Right Now
|
|
Apr 3
|
Investing in Alcon (VTX:ALC) five years ago would have delivered you a 29% gain
|
|
Mar 26
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
|
Mar 19
|
Here's Why We Think Alcon (VTX:ALC) Might Deserve Your Attention Today
|
|
Mar 13
|
Alcon's (ALC) New Launch Strengthens IOL Innovation Leadership
|
|
Mar 12
|
Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India
|
|
Mar 8
|
Alcon's (ALC) Vivity EDOF IOL Achieves One Million Milestone
|
|
Mar 6
|
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone
|
|
Mar 6
|
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
|
|
Jan 10
|
Good News For Dry Eye Disease Patients: Eye Care Focused Alcon's Treatment Shows Encouraging Benefit In Late-Stage Trials
|
|
Jan 9
|
Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye
|